USA Change Macroaxis User Registration

Home Portfolios Solutions About Us

More ROI Blog

Marketplace Community ScreenersEfficient FrontierCorrelationsRisk/Return

US Market Open: Feb 8, 13:39 PM 2012

NYSE 8062.46 7.25 Index Moved Down

NASDAQ 2908.42 4.34 Index Moved Up

and more..

sponsered by

Processing
Collecting necessary data for SLXP and NUTR...

Asset Comparison and Correlation

View All Portfolios

More Actions
- Select Assests
- Optimize Portfolio
- Suggest Portfolio
- Backtest Watchlist
- Analyze Correlations
- View Transactions
- Check Volatilities
- Import Equities
- Search Equities
- Filter Tops

Salix Pharmaceuticals Ltd. and

Nutraceutical International Co

Volatility

Matrix

Run Correlation

Diversification

Good diversification

Overlapping area represents amount of risk that can be diversified away by holding Salix Pharmaceuticals Ltd. and Nutraceutical International Co in the same portfolio (assuming nothing else is changed)

Optimize

Correlation Coefficient

-0.15

Parameters

Time Period	1 Month [change]
Direction	Negative
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Suggest

Salix Pharmaceuticals Ltd.

Profile

48.74

Intraday

One Month

^0.31

0.64%

SLXP

NASDAQ

Salix Pharmaceuticals Ltd.

P/E	37.25	Day Low	48.33
Open	48.74	P/B Ratio	5.96
Market Cap	2.882B	Volume	206077
Sector	Healthcare	Last Close	48.43
Short Ratio	7.80	Last Traded	2/8/2012
Year High	50.28	Percent Change	0.64%
EBITDA	142.7M	Year Low	25.64
Absolute Change	0.31	Time	Not Applicable
Book Value	8.127	EPS	1.30
PEG Ratio	0.93	Employees	390
Day High	49.09	Industry	Drugs - Generic
Target Price	54.53	Current EPS	1.30
This Year EPS	2.53	Next Year EPS	2.78
Current PE	37.25	This Year PE	19.14
Next Year PE	17.42	Dividend	Not Applicable

Nutraceutical International Cor

Profile

13.98

Intraday

One Month

^(0.15)

1.06%

NUTR

NASDAQ

Nutraceutical International Co

P/E	9.61	Day Low	13.95
Open	14.15	P/B Ratio	1.16
Market Cap	139.0M	Volume	5700
Sector	Healthcare	Last Close	14.13
Short Ratio	10.70	Last Traded	2/8/2012
Year High	15.99	Percent Change	1.06%
EBITDA	32.8M	Year Low	10.65
Absolute Change	0.15	Time	Not Applicable
Book Value	12.195	EPS	1.471
Employees	727	Day High	14.1408
Target Price	17.00	Current EPS	1.471
This Year EPS	1.72	Next Year EPS	1.77
Current PE	9.61	This Year PE	8.22
Next Year PE	7.98	Dividend	Not Applicable